Literature DB >> 9202215

Effects of RU486 on estrogen, progesterone, oxytocin, and their receptors in the rat uterus during late gestation.

X Fang1, S Wong, B F Mitchell.   

Abstract

Oxytocin (OT) and its receptor (OTR) are synthesized in the endometrium and myometrium of the pregnant rat during late gestation. Both are regulated by estrogen and progesterone (P4), and tissue concentrations of both increase markedly before parturition. The P4 antagonist RU486 will induce parturition in the rat. The purpose of the present studies was to investigate changes in OT and OTR messenger RNA (mRNA) and peptide synthesis within the pregnant rat uterus during RU486-induced parturition. Pregnant rats were given a single injection of RU486 (2.5 mg/rat in oil) on day 15 of pregnancy (normal delivery occurs on day 22). Control animals received injections of oil only. Groups of animals (n = 5 in each group) were euthanized at 0, 6, 12, 24, and 48 h after injection and during labor (immediately after delivery of the first pup). Maternal serum estradiol (E2), P4 and uterine OT, and PGE2 concentrations were measured by RIA. Prostaglandin F2alpha and estrogen receptor levels were measured by enzyme immunoassay (EIA). OTR and P4 receptor (PR) were measured using radioligand-binding assays. OT, OTR, and estrogen receptor mRNAs were measured with ribonuclease protection assays. The average time to delivery, after RU486 injection, was 27.0 +/- 1.2 h. Serum E2 and P4 levels were increased slightly, but significantly, at 24 h after RU486. In controls, OT mRNA increased significantly, and this increase was blocked in the RU486 treatment group. OTR mRNA levels increased within 6 h of RU486 and remained elevated until delivery. OTR peptide was increased by 12 h. PGE2 and PGF2alpha were increased 3-fold and 16-fold, respectively, but not until after the increase in OTR had occurred. We conclude that the mechanism of action of RU486 is to inhibit the P4 suppression of OTR synthesis, allowing increased expression of OTR, which may directly stimulate myometrial contractions or act indirectly through increased synthesis of PGs.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9202215     DOI: 10.1210/endo.138.7.5247

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  13 in total

Review 1.  Estrogen receptor-α and estrogen receptor-β in the uterine vascular endothelium during pregnancy: functional implications for regulating uterine blood flow.

Authors:  Mayra B Pastore; Sheikh O Jobe; Jayanth Ramadoss; Ronald R Magness
Journal:  Semin Reprod Med       Date:  2012-01-23       Impact factor: 1.303

2.  Progesterone Receptor-Mediated Actions Regulate Remodeling of the Cervix in Preparation for Preterm Parturition.

Authors:  Michael A Kirby; Anne C Heuerman; Melisa Custer; Abigail E Dobyns; Ryan Strilaeff; Kathleen N Stutz; Jaclyn Cooperrider; Joseph G Elsissy; Steven M Yellon
Journal:  Reprod Sci       Date:  2016-05-27       Impact factor: 3.060

Review 3.  Exploring the causes and consequences of maternal metabolic maladaptations during pregnancy: Lessons from animal models.

Authors:  Amanda N Sferruzzi-Perri; Jorge Lopez-Tello; Tina Napso; Hannah E J Yong
Journal:  Placenta       Date:  2020-01-31       Impact factor: 3.481

4.  Smoothelin-like 1 protein is a bifunctional regulator of the progesterone receptor during pregnancy.

Authors:  Khaldon Bodoor; Beata Lontay; Rachid Safi; Douglas H Weitzel; David Loiselle; Zhengzheng Wei; Szabolcs Lengyel; Donald P McDonnell; Timothy A Haystead
Journal:  J Biol Chem       Date:  2011-07-19       Impact factor: 5.157

5.  Progesterone withdrawal promotes remodeling processes in the nonpregnant mouse cervix.

Authors:  Steven M Yellon; Alexandra E Burns; Jennifer L See; Thomas J Lechuga; Michael A Kirby
Journal:  Biol Reprod       Date:  2009-02-18       Impact factor: 4.285

6.  Relationship between gene expression and function of uterotonic systems in the rat during gestation, uterine activation and both term and preterm labour.

Authors:  Patrice Arthur; Michael J Taggart; Barbara Zielnik; Susan Wong; Bryan F Mitchell
Journal:  J Physiol       Date:  2008-10-20       Impact factor: 5.182

Review 7.  Mifepristone for induction of labour.

Authors:  Dharani Hapangama; James P Neilson
Journal:  Cochrane Database Syst Rev       Date:  2009-07-08

8.  Loss of progesterone receptor-mediated actions induce preterm cellular and structural remodeling of the cervix and premature birth.

Authors:  Steven M Yellon; Abigail E Dobyns; Hailey L Beck; James T Kurtzman; Robert E Garfield; Michael A Kirby
Journal:  PLoS One       Date:  2013-12-10       Impact factor: 3.240

9.  Uterine and placental expression of TRPV6 gene is regulated via progesterone receptor- or estrogen receptor-mediated pathways during pregnancy in rodents.

Authors:  Bo-Mi Lee; Geun-Shik Lee; Eui-Man Jung; Kyung-Chul Choi; Eui-Bae Jeung
Journal:  Reprod Biol Endocrinol       Date:  2009-05-21       Impact factor: 5.211

10.  Progesterone is essential for protecting against LPS-induced pregnancy loss. LIF as a potential mediator of the anti-inflammatory effect of progesterone.

Authors:  Julieta Aisemberg; Claudia A Vercelli; María V Bariani; Silvia C Billi; Manuel L Wolfson; Ana M Franchi
Journal:  PLoS One       Date:  2013-02-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.